T. Rowe Price Associates
BHC icon

T. Rowe Price Associates’s Bausch Health BHC Stock Holding History

T. Rowe Price Associates’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,402,927
Closed -$39.1M – 2986
2021
Q3 		$39.1M Sell
1,402,927
-6,447,646
-82% -$183M ﹤0.01% 1103
2021
Q2 		$230M Buy
7,850,573
+2,553,297
+48% +$77.4M 0.02% 524
2021
Q1 		$168M Sell
5,297,276
-572,585
-10% -$16.8M 0.02% 602
2020
Q4 		$122M Sell
5,869,861
-4,952,841
-46% -$92.4M 0.01% 670
2020
Q3 		$168M Buy
10,822,702
+2,038,156
+23% +$35.1M 0.02% 527
2020
Q2 		$161M Buy
8,784,546
+6,269,935
+249% +$110M 0.02% 518
2020
Q1 		$39M Buy
+2,514,611
New +$60.6M 0.01% 861
2018
Q3 		– Sell
-9,200
Closed -$214K – 2585
2018
Q2 		$214K Buy
+9,200
New +$190K ﹤0.01% 2438
2016
Q4 		– Sell
-1,722,415
Closed -$42.2M – 2551
2016
Q3 		$42.2M Buy
1,722,415
+239,261
+16% +$6.19M 0.01% 869
2016
Q2 		$29.8M Sell
1,483,154
-665,647
-31% -$18.8M 0.01% 969
2016
Q1 		$56.5M Sell
2,148,801
-19,705,013
-90% -$1.46B 0.01% 725
2015
Q4 		$2.22B Buy
21,853,814
+1,806,903
+9% +$203M 0.47% 43
2015
Q3 		$3.58B Sell
20,046,911
-416,721
-2% -$97.2M 0.8% 17
2015
Q2 		$4.55B Buy
20,463,632
+338,296
+2% +$75M 0.93% 14
2015
Q1 		$4B Buy
20,125,336
+2,283,052
+13% +$405M 0.83% 16
2014
Q4 		$2.55B Buy
17,842,284
+345,074
+2% +$46.4M 0.54% 34
2014
Q3 		$2.3B Buy
17,497,210
+1,041,503
+6% +$124M 0.5% 46
2014
Q2 		$2.08B Buy
16,455,707
+2,398,880
+17% +$306M 0.45% 52
2014
Q1 		$1.85B Sell
14,056,827
-726,776
-5% -$99.4M 0.42% 49
2013
Q4 		$1.74B Sell
14,783,603
-720,732
-5% -$79M 0.4% 55
2013
Q3 		$1.62B Buy
15,504,335
+13,065
+0.1% +$1.27M 0.4% 59
2013
Q2 		$1.33B Buy
+15,491,270
New +$1.22B 0.36% 66

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

T. Rowe Price Associates's BHC Position: Q4 2021 in Review

T. Rowe Price Associates sold out of Bausch Health (BHC) in Q4 2021, closing a stake of 1,402,927 shares — an estimated $39.1M sold.

T. Rowe Price Associates first reported a position in BHC in Q2 2013 and held it in 22 quarters. The position peaked at $4.55B in Q2 2015. 377 funds tracked by Wall St. Rank hold BHC as of Q4 2021.

  • T. Rowe Price Associates reported no remaining Bausch Health position as of Q4 2021 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,402,927 Bausch Health shares in Q4 2021, an estimated $39.1M.
  • T. Rowe Price Associates first reported a position in Bausch Health in Q2 2013 and held it in 22 quarters.
  • T. Rowe Price Associates's Bausch Health position peaked at $4.55B in Q2 2015.
  • 377 funds tracked by Wall St. Rank held Bausch Health as of Q4 2021.

Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.